BiotechTube
Home/Retension Pharmaceuticals/Paul Sweetnam
PS

Paul Sweetnam

Chief Scientific Officer & Co-Founder

Retension Pharmaceuticals

Therapeutic Areas

CardiovascularHypertension

Retension Pharmaceuticals Pipeline

DrugIndicationPhase
RTN-001Uncontrolled HypertensionPhase 2

Leadership Team at Retension Pharmaceuticals

EK
Eric Keller
Chief Executive Officer, Founder & Chairman
WS
William Sasiela
Chief Medical Officer
View full Retension Pharmaceuticals profile